We Could Have Had Ozempic Nearly 40 Years Ago
Researchers identified one key breakthrough for GLP-1 drugs in the 1980s, but Pfizer walked away.
Robert F. Kennedy Jr. Wants to Ban Drug Ads on TV. It Wouldn’t Be Easy.
Attempts to restrict pharmaceutical advertisements have failed many times over the years, often on First Amendment grounds.
As Drug Culture Becomes Mainstream, Our Language Needs To Evolve.
We need a new language to talk about the chemicals and plants that change our consciousness.
What Kennedy’s Approach to Addiction Gets Wrong
America can’t go backward on drug policy.
R.F.K. Jr. Wants to Overhaul the F.D.A. How Would Scientists Change It?
While some agree with Robert F. Kennedy Jr. that the agency needs reform, their ideas for fixing it are very different from his.
A Woman With a Rare Gene Mutation Fights to Avoid Her Mother’s Fate
A mutant gene is coming to steal Linde Jacobs’s mind. Can she find a way to stop it?
As Drugstores Close, Older People Are Left in ‘Pharmacy Deserts’
Shuttered drugstores pose a particular threat to older adults, who take more medications than younger people and often rely on pharmacies for advice.
F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition.
Cómo dormir de verdad en un avión
Estas estrategias probadas pueden ayudarte a conseguir cierto grado de descanso, incluso en un poco conveniente asiento vertical.
Popular Arthritis Drug For Dogs May Have Severe Side Effects, F.D.A. Says
The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse reactions.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.